<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="6080">
  <stage>Registered</stage>
  <submitdate>5/06/2016</submitdate>
  <approvaldate>5/06/2016</approvaldate>
  <nctid>NCT02903615</nctid>
  <trial_identification>
    <studytitle>Optimising Health in Type 1 Diabetes</studytitle>
    <scientifictitle>The Optimal Diet for Optimising Health in Type 1 Diabetes</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>16/053</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Diabetes Mellitus</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Other interventions - Novel diet
Other interventions - Standard diet

Experimental: Novel type 1 diet - Experimental diet to be examined: altered macronutrient composition: lower carbohydrate, Mediterranean-style, prebiotic fibre focus.

Placebo Comparator: Standard therapy - Standard dietary therapy, as promulgated by Australian standards


Other interventions: Novel diet
Novel diet to optimise glucose levels and minimise systemic inflammation: altered macronutrient composition: lower carbohydrate, Mediterranean-style, prebiotic fibre focus.

Other interventions: Standard diet
Standard diabetes diet recommendations

</interventions>
    <comparator />
    <control />
    <interventioncode>Other interventions interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Glucose control - HbA1c</outcome>
      <timepoint>3 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Inflammation - Circulating immune cells numbers</outcome>
      <timepoint>3 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Gut microbiome - Gut flora subtypes</outcome>
      <timepoint>3 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>C-peptide - Urinary excretion</outcome>
      <timepoint>3 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>postprandial glucose excursion - postprandial glucose excursion</outcome>
      <timepoint>3 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  type 1 diabetes</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>-  Women lactating, pregnant or of childbearing potential who are not willing to avoid
             becoming pregnant during the study.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/09/2016</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/12/2018</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>professor Katherine Samaras - Sydney</hospital>
    <hospital>Garvan Institute to Medical Research - Sydney</hospital>
    <postcode>2010 - Sydney</postcode>
    <postcode> - Sydney</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Garvan Institute of Medical Research</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>Type 1 diabetes is an autoimmune condition where circulating immune cells destroy the
      beta-cells in the pancreas that make insulin, resulting in a degree of insulin deficiency,
      whereby blood glucose levels rise and diabetes develops. When there is severe insulin
      deficiency, life-threatening ketoacidosis can develop. Treatment is lifelong insulin
      replacement therapy; dietary intervention is a also cornerstone of glucose management.

      The Optimise Diet is a multi-pronged diet based on "best health" principles: to minimise
      blood glucose rises after eating, reduce the immune cells involved in destruction of the
      insulin-secreting beta-cells, and improve the gut microbiome and systemic inflammation. In
      this study, its effects will be compared to the Standard Diabetes Diet that is currently
      recommended in Australia and internationally.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02903615</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Katherine Samaras, MD PhD FRACP</name>
      <address>Garvan Institute of Medical Research</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Katherine Samaras</name>
      <address />
      <phone />
      <fax />
      <email>k.samaras@garvan.org.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>